Literature DB >> 22930404

Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study.

Jill M Cyranowski1, Laura L Schott, Howard M Kravitz, Charlotte Brown, Rebecca C Thurston, Hadine Joffe, Karen A Matthews, Joyce T Bromberger.   

Abstract

BACKGROUND: In clinical samples, comorbidity between depressive and anxiety disorders is associated with greater symptom severity and elevated suicide risk. Less is known, however, regarding the long-term psychosocial impact that a lifetime history of both major depressive disorder (MDD) and one or more anxiety disorders has in community samples. This report evaluates clinical, psychological, social, and stress-related characteristics associated with a lifetime history of MDD and anxiety.
METHODS: Data from 915 women aged 42-52 who were recruited as part of the the Study of Women's Health across the Nation (SWAN) Mental Health Study were used to examine clinical and psychosocial features across groups of women with a lifetime history of MDD alone, anxiety alone, both MDD and anxiety, or neither MDD nor anxiety.
RESULTS: As compared with women with a history of either MDD or anxiety alone, women with a comorbid history were more likely to report recurrent MDD, multiple and more severe lifetime anxiety disorders, greater depressive and anxiety symptoms, diminished social support, and more past-year distressing life events. Exploratory analyses indicated that women with a comorbid history also report more childhood abuse/neglect and diminished self-esteem, as compared with women with a history of either disorder alone.
CONCLUSIONS: Midlife women with a comorbid history that includes both MDD and anxiety disorders report diminished social support, more symptomatic distress, and a more severe and recurrent psychiatric history. Future research is needed to clarify the biological and psychosocial risk factors associated with this comorobid profile, and to develop targeted interventions for this at-risk group. Depression and Anxiety 00:1-8, 2012.
© 2012 Wiley Periodicals, Inc. © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22930404      PMCID: PMC3592574          DOI: 10.1002/da.21990

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  40 in total

1.  Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Authors:  T A Brown; L A Campbell; C L Lehman; J R Grisham; R B Mancill
Journal:  J Abnorm Psychol       Date:  2001-11

2.  Cardiac vagal control in nonmedicated depressed women and nondepressed controls: impact of depression status, lifetime trauma history, and respiratory factors.

Authors:  Jill M Cyranowski; Tara L Hofkens; Holly A Swartz; Kristen Salomon; Peter J Gianaros
Journal:  Psychosom Med       Date:  2011-03-01       Impact factor: 4.312

3.  Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders.

Authors:  T A Brown; P A Di Nardo; C L Lehman; L A Campbell
Journal:  J Abnorm Psychol       Date:  2001-02

4.  Childhood adversity and anxiety versus dysthymia co-morbidity in major depression.

Authors:  Kate L Harkness; Jennifer E Wildes
Journal:  Psychol Med       Date:  2002-10       Impact factor: 7.723

5.  Major depressive disorder and axis I diagnostic comorbidity.

Authors:  Mark Zimmerman; Iwona Chelminski; Wilson McDermut
Journal:  J Clin Psychiatry       Date:  2002-03       Impact factor: 4.384

6.  Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking.

Authors:  P P Roy-Byrne; P Stang; H U Wittchen; B Ustun; E E Walters; R C Kessler
Journal:  Br J Psychiatry       Date:  2000-03       Impact factor: 9.319

7.  The childhood trauma questionnaire in a community sample: psychometric properties and normative data.

Authors:  C D Scher; M B Stein; G J Asmundson; D R McCreary; D R Forde
Journal:  J Trauma Stress       Date:  2001-10

8.  Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.

Authors:  Tarja K Melartin; Heikki J Rytsälä; Ulla S Leskelä; Paula S Lestelä-Mielonen; T Petteri Sokero; Erkki T Isometsä
Journal:  J Clin Psychiatry       Date:  2002-02       Impact factor: 4.384

9.  Interpersonal dysfunction in depressed women: impairments independent of depressive symptoms.

Authors:  Constance Hammen; Patricia A Brennan
Journal:  J Affect Disord       Date:  2002-11       Impact factor: 4.839

10.  Emotional and cardiovascular reactivity to a child-focused interpersonal stressor among depressed mothers of psychiatrically ill children.

Authors:  Jill M Cyranowski; Holly A Swartz; Tara L Hofkens; Ellen Frank
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

View more
  15 in total

1.  A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder.

Authors:  Ranran Li; Renrong Wu; Jun Chen; David E Kemp; Ming Ren; Carla Conroy; Philip Chan; Mary Beth Serrano; Stephen J Ganocy; Joseph R Calabrese; Keming Gao
Journal:  Psychopharmacol Bull       Date:  2016-03-01

2.  High rates of comorbid depressive and anxiety disorders among women with premutation of the FMR1 gene.

Authors:  Heather A Kenna; Molly Tartter; Scott S Hall; Amy A Lightbody; Quynh Nguyen; C Paula de los Angeles; Allan L Reiss; Natalie L Rasgon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-09-03       Impact factor: 3.568

3.  Combined effects of depression and anxiety on suicide: A case-control psychological autopsy study in rural China.

Authors:  Jie Zhang; Xinxia Liu; Le Fang
Journal:  Psychiatry Res       Date:  2018-11-06       Impact factor: 3.222

4.  Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder.

Authors:  Wanqiu Yang; Miao Qu; Rui Jiang; XiaoE Lang; Xiang-Yang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-18       Impact factor: 5.760

5.  Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder.

Authors:  Takeshi Inoue; Toshifumi Kimura; Yoshifumi Inagaki; Osamu Shirakawa
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-12       Impact factor: 2.570

6.  Depression, Social Support, and Coping Styles among Pregnant Women after the Lushan Earthquake in Ya'an, China.

Authors:  Jianhua Ren; Xiaolian Jiang; Jianrong Yao; Xirong Li; Xinghui Liu; Meiche Pang; Chung Lim Vico Chiang
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

7.  Diagnostic criteria for depression in type 2 diabetes: a data-driven approach.

Authors:  Sergio E Starkstein; Wendy A Davis; Milan Dragovic; Violetta Cetrullo; Timothy M E Davis; David G Bruce
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

8.  Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder.

Authors:  Yongjie Zhou; Zhongqiang Cao; Mei Yang; Xiaoyan Xi; Yiyang Guo; Maosheng Fang; Lijuan Cheng; Yukai Du
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

9.  Depression and anxiety behaviour in a rat model of chronic migraine.

Authors:  Mingjie Zhang; Yufei Liu; Mangsuo Zhao; Wenjing Tang; Xiaolin Wang; Zhao Dong; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-02-21       Impact factor: 7.277

10.  Factors Associated with Psychiatric Comorbidity in Depression Patients in Primary Health Care in Chile.

Authors:  Alfredo Cancino; Marcelo Leiva-Bianchi; Carlos Serrano; Soledad Ballesteros-Teuber; Cristian Cáceres; Verónica Vitriol
Journal:  Depress Res Treat       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.